Logo

Bruker's Q3 Revenues Rise 22 Percent as Profit Increases by a Third

Nov 02, 2006
NEW YORK (GenomeWeb News) — Bruker Biosciences’ third-quarter revenue increased 22 percent as income jumped by a third, the company said today.
 
Receipts for the three months ended Sept. 30 rose to $104.8 million from $85.9 million year over year. Product revenues were up 22 percent to $50.1 million and receipts from the company’s services business tallied $8 million, a third more than the same period last year.
 
The company attributed much of the revenue growth to its acquisition of Bruker Optics for $135 million in July.
 
Bruker said it will continue to look for ways to improve organic earnings in its core business.      
 
Spending on research and development remained flat at $12 million.
 
Bruker said profits in the period increased by a third to $3 million.
 
The company said it had around $44.1 million in cash and short term investments as of Sept. 30.

Breaking News
The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.